Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · January 18, 2022

Donor-Derived cfDNA as a Marker of Acute Lung Allograft Dysfunction

The Journal of Heart and Lung Transplantation

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Journal of Heart and Lung Transplantation
Donor-derived Cell-free DNA as a Composite Marker of Acute Lung Allograft Dysfunction in Clinical Care
J. Heart Lung Transplant 2021 Dec 26;[EPub Ahead of Print], M Keller, J Sun, C Mutebi, et al

Further Reading